Medicare Enrolled
Dr. Jeffrey Retig, M.D.
Gastroenterology · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Retig from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Retig?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Retig
Dr. Jeffrey Retig is a gastroenterology specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Retig performed 587 Medicare services across 540 unique beneficiaries.
Between the years covered by Open Payments, Dr. Retig received a total of $21,233 from 55 pharmaceutical and/or device companies across 990 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Retig is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 38% volume in PA
$21,233 industry payments
Medicare Practice Summary
Medicare Utilization ↗587
Medicare services
Top 38% in PA for gastroenterology
540
Unique beneficiaries
$140
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| New patient office visit, complex (60-74 min) | 85 | $173 | $312 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
66 | $144 | $277 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
64 | $86 | $699 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
64 | $105 | $570 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $141 | $312 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
62 | $98 | $263 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
57 | $219 | $1,045 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
53 | $187 | $633 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $104 | $209 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
17 | $152 | $633 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
14 | $88 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $134 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,233
Total received (2018-2024)
Avg $3,033/year across 7 years
Top 12% in PA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
990
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,750 (69.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,542 (26.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$941 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,970
2023
$1,879
2022
$2,537
2021
$1,798
2020
$934
2019
$8,148
2018
$2,967
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$797
Janssen Biotech, Inc.
$306
Takeda Pharmaceuticals U.S.A., Inc.
$285
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$221
Celgene Corporation
$215
Madrigal Pharmaceuticals
$164
PFIZER INC.
$158
Alexion Pharmaceuticals, Inc.
$148
Regeneron Healthcare Solutions, Inc.
$99
IRONWOOD PHARMACEUTICALS, INC
$86
Celltrion USA Inc.
$85
Phathom Pharmaceuticals, Inc.
$85
Lilly USA, LLC
$77
Ardelyx, Inc.
$50
Daiichi Sankyo Inc.
$50
GENZYME CORPORATION
$36
QOL Medical, LLC
$36
Ipsen Biopharmaceuticals, Inc
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Gilead Sciences, Inc.
$17
Sandoz Inc.
$16
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$5,984
ABBVIE INC.
$2,256
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,176
Takeda Pharmaceuticals U.S.A., Inc.
$1,355
Janssen Biotech, Inc.
$1,018
Allergan Inc.
$970
AbbVie Inc.
$960
Celgene Corporation
$807
AbbVie, Inc.
$734
Ironwood Pharmaceuticals, Inc
$402
Regeneron Healthcare Solutions, Inc.
$396
Merck Sharp & Dohme Corporation
$332
UCB, Inc.
$287
QOL Medical, LLC
$271
Ferring Pharmaceuticals Inc.
$240
Alexion Pharmaceuticals, Inc.
$233
Shire North American Group Inc
$215
Daiichi Sankyo Inc.
$211
Synergy Pharmaceuticals Inc
$209
Bayer HealthCare Pharmaceuticals Inc.
$198
Madrigal Pharmaceuticals
$164
AstraZeneca Pharmaceuticals LP
$125
E.R. Squibb & Sons, L.L.C.
$120
Flexion Therapeutics, Inc.
$119
Janssen Scientific Affairs, LLC
$113
IRONWOOD PHARMACEUTICALS, INC
$103
Gilead Sciences, Inc.
$101
Shionogi Inc
$95
Nestle HealthCare Nutrition Inc.
$94
GENZYME CORPORATION
$92
Boston Scientific Corporation
$91
Celltrion USA Inc.
$85
Phathom Pharmaceuticals, Inc.
$85
Ardelyx, Inc.
$84
Lilly USA, LLC
$77
Intercept Pharmaceuticals, Inc.
$76
Amgen Inc.
$46
RedHill Biopharma Inc.
$40
Merck Sharp & Dohme LLC
$24
Ipsen Biopharmaceuticals, Inc
$21
BOSTON SCIENTIFIC CORPORATION
$18
Digestive Care, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Concordia Pharmaceuticals Inc.
$18
Prometheus Laboratories Inc.
$18
NESTLE HEALTHCARE NUTRITION INC.
$17
Sandoz Inc.
$16
VIVUS, Inc.
$15
Braintree Laboratories, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
ALBIREO PHARMA, INC.
$13
Medtronic, Inc.
$13
Cumberland Pharmaceuticals, Inc.
$12
Romark Laboratories, LC
$6
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Aemcolo · Alinia · Amitiza · BREATHTEK · Bylvay · CIMZIA · CLENPIQ · CREON · CYCLOSET · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · ENTYVIO · EOHILIA · Entyvio · FARXIGA · GATTEX · GENERAL - ENDOCHOICE · GI Genius · GIVLAARI · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · INJECTAFER · IQIRVO · KRISTALOSE · Kanuma · Kerendia · LINZESS · LYRICA · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · ORISE · PANCREAZE · PREPOPIK · Pertzye · REBYOTA · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPYGLASS · STELARA · STRENSIQ · SUCRAID · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trapezoid RX · Trulance · UBRELVY · UCERIS · UCERIS TABLETS · VEGZELMA · VIBERZI · VOQUEZNA · WallFlex Duodenal · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA · ZYMFENTRA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
414
Per 100K population
71.9
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Retig is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Retig experienced with new patient office visit, complex (60-74 min)?
Based on Medicare claims data, Dr. Retig performed 85 new patient office visit, complex (60-74 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Retig receive payments from pharmaceutical companies?
Yes. Dr. Retig received a total of $21,233 from 55 companies across 990 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Retig's costs compare to other gastroenterologists in Bryn Mawr?
Dr. Retig's average Medicare payment per service is $140. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Retig) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Bryn Mawr
Browse gastroenterologists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in PA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in PA
Which PA gastroenterologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology